最後更新：2026年10月1日
肥大細胞瘤,常見的皮膚惡性腫瘤。預後取決於組織學分級與臨床分期,需外科切除並考慮輔助治療。
Lymphoma is the most common feline malignancy. Alimentary (GI) lymphoma predominates, with small cell (low-grade) vs large cell (high-grade) distinction guiding prognosis and treatment. FeLV-associated mediastinal lymphoma has decreased with vaccination. Injection-site sarcoma (feline injection-site sarcoma, FISS) requires wide surgical margins (3-5 cm).
這頁有幾個欄位是同系統共用的模板，還沒針對本疾病單獨改寫過。請以臨床判斷為準，記得對照下方文獻。
曲安西龍。Corticosteroid
建議：化療前後積極利尿（cisplatin）或維持量
| 藥物 | 劑量 | 頻率 | 路徑 | 優先級 |
|---|---|---|---|---|
| Butorphanol Tartrate 布托啡諾。Analgesic | 貓 0.05-0.2 mg/kg q4-6h IV/IM/SC | Q4-6H | IV | 首選 |
| 藥物 | 劑量 | 頻率 | 優先級 |
|---|---|---|---|
| Cyclophosphamide 環磷醯胺。Anticancer agent | 貓 200-250 mg/m2 q21 days PO | 依醫囑 | 首選 |
| Triamcinolone Acetonide, Triamcinolone Hexacetonide, Triamcinolone Diacetate 曲安西龍。Corticosteroid | 貓 0.5-1 mg/kg q12-24h PO | Q12-24H | 首選 |
| Polymyxin B 多黏菌素B。NSAID | 貓 Refer to current formulary for species-specific dosing | 依醫囑 | 首選 |
| Gabapentin 加巴噴丁。Gabapentinoid (Anticonvulsant / Analgesic) | 貓 5-10 mg/kg q8-12h PO | Q8-12H | 首選 |
監測頻率：化療後 7-10d (nadir)
[1]Genetic Changes in Mastocytes and Their Significance in Mast Cell Tumor Prognosis and Treatment.
[2]Successful treatment of cutaneous mast cell tumors in cats using electrochemotherapy: A case series.
[3]Lymph node metastasis in feline cutaneous low-grade mast cell tumours.
[4]Feline maculopapular cutaneous mastocytosis: a retrospective study of 13 cases and proposal for a new classification.
[5]Retrospective study of more than 9000 feline cutaneous tumours in the UK: 2006-2013.
需系統性診斷與治療計畫，延遲可能影響預後 (systematic workup needed, delay may affect prognosis)
預後高度變異,取決於腫瘤類型、分級、分期與治療方式。早期診斷與積極治療可延長存活期。
Feline Mast Cell Tumor Cutaneous 診斷流程
詳細問診包括發病經過、用藥史、飲食與環境
CBC、生化全套、尿液分析
來源：自動產生